# KRSA catalysts: Korsana Biosciences, Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/krsa/catalysts

> Korsana Biosciences, Inc. (KRSA) has no upcoming catalysts in this calendar. The latest recorded is the Korsana Biosciences, Inc. earnings report, November 5, 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day, half-year only, quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Korsana Biosciences, Inc. |
| Ticker | KRSA (Nasdaq) |
| SEC CIK | 1755237 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/krsa |

## Cash runway

Cash $456.2M as of 2026-09-30; quarterly burn $46.8M; about 29.2 months of runway at that rate (XBRL company facts, accession 0001193125-26-448636).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| March 5, 2024 | [Korsana Biosciences, Inc. interim data readout](https://sec-api.dev/companies/krsa/catalysts) | KRSA |  | completed, positive | "Asset was in Ph1 SAD in HVs. **Apogee: Positive interim data from Ph1 SAD in HVs disclosed 5 March 2024." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1755237/000119312526137909/d128275dex992.htm)) |
| 2H 2026 | [CYC-126 trial start](https://sec-api.dev/pdufa/cyc-126) | KRSA |  | scheduled | "-Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC") Study in Treatment Resistant Depression ("TRD") in the Second Half of 2026-" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1755237/000119312526053035/d104475dex991.htm)) |
| Q4 2026 | [Korsana Biosciences, Inc. topline data readout](https://sec-api.dev/companies/krsa/catalysts) | KRSA |  | scheduled | "The study enrolled approximately 43 participants, and Tisento has indicated that top-line results are expected in the fourth quarter of 2026." ([SEC Form 10-K](https://www.sec.gov/Archives/edgar/data/1755237/000119312526132193/cycn-20251231.htm)) |
| November 5, 2026 | [Korsana Biosciences, Inc. earnings report](https://sec-api.dev/companies/krsa/catalysts) | KRSA |  | completed | "Korsana Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1755237/000119312526448535/krsa-ex99_1.htm)) |

## Drugs

- [CYC-126](https://sec-api.dev/pdufa/cyc-126): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/krsa/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "KRSA catalysts: Korsana Biosciences, Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/krsa/catalysts

```bibtex
@misc{secapidev_companies_krsa_catalysts_20261116,
  title        = {KRSA catalysts: Korsana Biosciences, Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/krsa/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_krsa_catalysts_20261116","title":"KRSA catalysts: Korsana Biosciences, Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/krsa/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
